Skip to content

Evaluation of Effectiveness of Ambulatory Geriatric Rehabilitation

Evaluation of Effectiveness of Ambulatory Geriatric Rehabilitation - EAGER

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00008926
Enrollment
900
Registered
2015-07-29
Start date
2008-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Progression of nursing care level, admission to nursing home, hospital admission, ambulatory nursing care, fractures and fall-related injuries (ICD-10-GM diagnosis codes: Sxx, Txx), multimorbidity S02 S12 S22 S32 S42 S52 S62 S72 T02 T10 T12 T14.2 S00 S01 S03 S06 S11 S20 S21 S30 S33 S40 S41 S43 S50 S51 S53 S60 S61 S63 S70 S71 S73 T00 T01 T03 T11 T14

Interventions

many-to-one matching with presumably 4 controls for each AGR participant
Group 1: Intervention group: Participation in the ambulatory geriatic programme (AGR) at one of the three participating rehabilitations centres in Mecklenburg-Vorpommern, Germany
The programme spans 20 therapy days (2-3 therapy sessions per day), and typically lasts 4 weeks Group 2: (Matched) Control group: no AGR

Sponsors

Universitätsmedizin Greifswald
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: The target population is defined by the eligibility requirements as stipulated by the statutory health insurance. The global criteria are: age >= 70 years, multimorbidity, impairment/handicap/functional deficits, and the presence of at least one of the following medical conditions based on ICD-10-GM diagnosis codes: I60 – I69, S72-, I70-, M16.-, M17.-, I50.-, J44.0, J44.1, J10 – J22, S00 – T98, M00 – M25, M45 – M51, I05 - I09, I20 – I25, G20.9, R29.5, R29.6, R29.8.

Exclusion criteria

Exclusion criteria: Exclusion criteria include: i) living in a nursing home or receive home nursing care level III, ii) they need hospital care or inpatient treatment, iii) solely curative measures have been indicated, iv) regimens are too burdensome, v) severe clinical or musculoskeletal impairments that prevent active participation, or comorbidities and other complication that prevent active participation, vi) consent declined

Design outcomes

Primary

MeasureTime frame
The main outcome comparing treated and untreated patients based on the claims data are progression of nursing care level, admission to nursing homes and ambulatory nursing care. Claims data from the health insurance fund AOK Nordost will be used. The follow-up period is 4 quarters after the end of the AGR intervention period.

Secondary

MeasureTime frame
Secondary outcomes are fractures, hospital admissions and inpatient days (per quarter), and costs from the health insurer perspective.On an exploratory basis we will assess the effects of AGR on different medical conditions using ICD-10 diagnosis codes and on mortality. Claims data from the health insurance fund AOK Nordost will be used. Moreover we will analyse the changes, comparing clinical data before and after the intervention regarding mobility, self-dependence and cognitive performance using only the clinical data from AGR participants.

Countries

Germany

Contacts

Public ContactJ.-F. Chenot

Abteilung für Allgemeinmedizin, Institut für Community Medicine, Universitätsmedizin Greifswald

allgemeinmedizin@uni-greifswald.de03834 86-22282

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 19, 2026